96 related articles for article (PubMed ID: 2344999)
1. Conversion of high grade lymphoma tumor cell line to intermediate grade with TPA and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis.
al-Katib A; Mohammad RM; Mohamed AN; Pettit GR; Sensenbrenner LL
Hematol Oncol; 1990; 8(2):81-9. PubMed ID: 2344999
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
Dale IL; Bradshaw TD; Gescher A; Pettit GR
Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoma cells.
Jalava A; Lintunen M; Heikkilä J
Biochem Biophys Res Commun; 1993 Mar; 191(2):472-8. PubMed ID: 8461005
[TBL] [Abstract][Full Text] [Related]
5. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
6. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha.
Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM
Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294
[TBL] [Abstract][Full Text] [Related]
7. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin 1 antagonizes the terminal differentiating action of 12-O-tetradecanoylphorbol-13-acetate in a human colon cancer cell.
McBain JA; Pettit GR; Mueller GC
Carcinogenesis; 1988 Jan; 9(1):123-9. PubMed ID: 3335036
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells.
Boorne AJ; Donnelly N; Schrey MP
Breast Cancer Res Treat; 1998 Mar; 48(2):117-24. PubMed ID: 9596483
[TBL] [Abstract][Full Text] [Related]
10. Induced expression of alpha-enolase in differentiated diffuse large cell lymphoma.
Mohammad RM; Hamdan MY; al-Katib A
Enzyme Protein; 1994-1995; 48(1):37-44. PubMed ID: 7787969
[TBL] [Abstract][Full Text] [Related]
11. Different effects of the two protein kinase C activators bryostatin-1 and TPA on growth and differentiation of human monocytic leukemia cell lines.
Steube KG; Grunicke D; Quentmeier H; Drexler HG
Leuk Res; 1993 Oct; 17(10):897-901. PubMed ID: 8412301
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
13. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Levine BL; May WS; Tyler PG; Hess AD
J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
[TBL] [Abstract][Full Text] [Related]
14. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
15. Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.
Gschwendt M; Fürstenberger G; Rose-John S; Rogers M; Kittstein W; Pettit GR; Herald CL; Marks F
Carcinogenesis; 1988 Apr; 9(4):555-62. PubMed ID: 2451575
[TBL] [Abstract][Full Text] [Related]
16. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
Steube KG; Grunicke D; Drexler HG
Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin.
Galron D; Ansotegui IJ; Isakov N
Cell Immunol; 1997 Jun; 178(2):141-51. PubMed ID: 9225005
[TBL] [Abstract][Full Text] [Related]
18. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
Nutt JE; Harris AL; Lunec J
Br J Cancer; 1991 Oct; 64(4):671-6. PubMed ID: 1911215
[TBL] [Abstract][Full Text] [Related]
19. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
Gschwend JE; Fair WR; Powell CT
Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines.
Mohammad RM; al-Katib A; Pettit GR; Sensenbrenner LL
Leuk Res; 1993 Jan; 17(1):1-8. PubMed ID: 8429674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
